Lobbying filed by CHAMBER OF COMMERCE OF THE U.S.A.
Lobbying filed by CHAMBER OF COMMERCE OF THE U.S.A.
Lobbying filed by CHAMBER OF COMMERCE OF THE U.S.A.
Lobbying filed by CHAMBER OF COMMERCE OF THE U.S.A.
Bill introduced
Read twice and referred to the Committee on Energy and Natural Resources.
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | $2337.0M | Apr 22, 2024 | 2024Q1 | AERAUTAVI |
| CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | $2241.0M | Jan 21, 2025 | 2024Q4 | AVIBANAER |
| CHAMBER OF COMMERCE OF THE U.S.A. |
Congress members who traded stocks in companies connected to lobbying on this bill, within 90 days of its introduction date.
| Member | Party | Ticker | Company | Trade | Date | Amount | Timing | Lobbying Client | Conflict |
|---|---|---|---|---|---|---|---|---|---|
| Robert P. Bresnahan, Jr. | R | K | K | Buy | Apr 8, 2025 | $1,001 - $15,000 | 26d after | AMERICAN CEMENT ASSOCIATION (FORMERLY KNOWN AS PORTLAND CEMENT ASSOCIATION) | 37% |
| Robert P. Bresnahan, Jr. | R |
16 trades by 3 members of Congress in companies connected to lobbying on S 1067. The average conflict score is 35%.
CapitolExposed identifies the "bill-lobbying-trade pipeline" by: (1) finding lobbying filings (LD-2) that specifically mention this bill, (2) matching lobbying clients to publicly traded companies, and (3) finding stock trades by members of Congress in those companies within 90 days of the bill's introduction date. Trades made before the bill was introduced are highlighted in red, as they may indicate advance knowledge. This analysis surfaces correlations worthy of scrutiny; it does not prove wrongdoing.
Robert P. Bresnahan, Jr. bought K
Robert P. Bresnahan, Jr. bought K
Robert P. Bresnahan, Jr. bought K
Robert P. Bresnahan, Jr. bought K
Robert P. Bresnahan, Jr. bought K
Lobbying filed by CHAMBER OF COMMERCE OF THE U.S.A.
| CHAMBER OF COMMERCE OF THE U.S.A. |
| $1934.0M |
| Apr 21, 2025 |
| 2025Q1 |
ENVFINFOR |
| CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | $1475.0M | Oct 21, 2024 | 2024Q3 | FORGOVHCR |
| CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | $1393.0M | Jul 22, 2024 | 2024Q2 | AERAUTAVI |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $960.0M | Apr 22, 2024 | 2024Q1 | BUDCPTHCR |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $756.0M | Jan 21, 2025 | 2024Q4 | BUDCPTHCR |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $696.0M | Jul 22, 2024 | 2024Q2 | BUDCPTHCR |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $688.0M | Oct 21, 2024 | 2024Q3 | BUDCPTHCR |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $480.4M | Apr 22, 2024 | 2024Q1 | MMMHCRPHA |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $416.5M | Oct 21, 2024 | 2024Q3 | MMMHCRPHA |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $358.2M | Jul 22, 2024 | 2024Q2 | MMMHCRPHA |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | BLUE CROSS AND BLUE SHIELD ASSOCIATION | $194.0M | Apr 22, 2024 | 2024Q1 | PHAHCRMMM |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | $179.0M | Jul 22, 2024 | 2024Q2 | AGRANIBUD |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | BLUE CROSS AND BLUE SHIELD ASSOCIATION | $176.0M | Jan 21, 2025 | 2024Q4 | PHAHCRMMM |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | $176.0M | Apr 22, 2024 | 2024Q1 | AGRANIBUD |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | $168.0M | Oct 21, 2024 | 2024Q3 | CHMMEDMMM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $154.0M | Oct 21, 2024 | 2024Q3 | BUDCPTHCR |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $151.0M | Jul 22, 2024 | 2024Q2 | BUDCPTHCR |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | $146.0M | Jan 21, 2025 | 2024Q4 | AGRANIBUD |
| TEVA PHARMACEUTICALS USA, INC. | TEVA PHARMACEUTICALS USA INC | $133.0M | Apr 19, 2024 | 2024Q1 | HCR |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | BLUE CROSS AND BLUE SHIELD ASSOCIATION | $121.0M | Jul 21, 2025 | 2025Q2 | PHAHCRMMM |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | BLUE CROSS AND BLUE SHIELD ASSOCIATION | $120.0M | Apr 21, 2025 | 2025Q1 | PHAHCRMMM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $92.0M | Jan 21, 2025 | 2024Q4 | BUDCPTHCR |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $82.0M | Apr 22, 2024 | 2024Q1 | BUDCPTHCR |
| KAISER FOUNDATION HEALTH PLAN INC. | KAISER FOUNDATION HEALTH PLAN INC | $68.0M | Jul 22, 2024 | 2024Q2 | ALCHCRMMM |
| CAMBIA HEALTH SOLUTIONS | CAMBIA HEALTH SOLUTIONS | $66.0M | Oct 17, 2024 | 2024Q3 | MMMHCR |
| CAMBIA HEALTH SOLUTIONS | CAMBIA HEALTH SOLUTIONS | $65.0M | Jul 19, 2024 | 2024Q2 | HCRMMM |
| CAMBIA HEALTH SOLUTIONS | CAMBIA HEALTH SOLUTIONS | $64.0M | Jan 21, 2025 | 2024Q4 | HCRMMM |
| CAMBIA HEALTH SOLUTIONS | CAMBIA HEALTH SOLUTIONS | $60.0M | Apr 12, 2024 | 2024Q1 | HCRMMM |
| AMRIZE NORTH AMERICA INC. | AMRIZE NORTH AMERICA INC. | $45.0M | Apr 21, 2025 | 2025Q1 | ENGENVTRA |
| TEVA PHARMACEUTICALS USA, INC. | TEVA PHARMACEUTICALS USA INC | $36.0M | Jan 17, 2025 | 2024Q4 | HCR |
| TEVA PHARMACEUTICALS USA, INC. | TEVA PHARMACEUTICALS USA INC | $31.0M | Oct 18, 2024 | 2024Q3 | HCR |
| BLUE CROSS BLUE SHIELD OF MICHIGAN | BLUE CROSS BLUE SHIELD OF MICHIGAN | $26.9M | Jan 21, 2025 | 2024Q4 | HCRMMMPHA |
| BLUE CROSS BLUE SHIELD OF MICHIGAN | BLUE CROSS BLUE SHIELD OF MICHIGAN | $26.6M | Jul 18, 2025 | 2025Q2 | HCRMMMPHA |
| BLUE CROSS BLUE SHIELD OF MICHIGAN | BLUE CROSS BLUE SHIELD OF MICHIGAN | $26.6M | Apr 21, 2025 | 2025Q1 | HCRMMMPHA |
| TEVA PHARMACEUTICALS USA, INC. | TEVA PHARMACEUTICALS USA INC | $25.0M | Jul 15, 2024 | 2024Q2 | HCR |
| AMERICAN CEMENT ASSOCIATION (FORMERLY PORTLAND CEMENT ASSOCIATION) | PORTLAND CEMENT ASSOCIATION | $24.0M | Jul 15, 2025 | 2025Q2 | ENVTRATAX |
| AMERICAN CEMENT ASSOCIATION (FORMERLY PORTLAND CEMENT ASSOCIATION) | PORTLAND CEMENT ASSOCIATION | $23.0M | Apr 10, 2025 | 2025Q1 | ENVTRATAX |
| KAISER FOUNDATION HEALTH PLAN INC. | KAISER FOUNDATION HEALTH PLAN INC | $22.0M | Jan 16, 2025 | 2024Q4 | DEFPHAALC |
| BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. | BLUE CROSS AND BLUE SHIELD OF FLORIDA INC | $21.0M | Apr 21, 2025 | 2025Q1 | HCRMMMPHA |
| KAISER FOUNDATION HEALTH PLAN INC. | KAISER FOUNDATION HEALTH PLAN INC | $21.0M | Oct 21, 2024 | 2024Q3 | HCRMMMTAX |
| AMRIZE NORTH AMERICA INC. | AMRIZE NORTH AMERICA INC. | $20.0M | Jul 20, 2025 | 2025Q2 | ENGENVTRA |
| BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. | BLUE CROSS AND BLUE SHIELD OF FLORIDA INC | $14.0M | Jan 17, 2025 | 2024Q4 | HCRMMMPHA |
| KAISER FOUNDATION HEALTH PLAN INC. | KAISER FOUNDATION HEALTH PLAN INC | $14.0M | Apr 23, 2024 | 2024Q1 | DEFHCRMMM |
| SIERRA CLUB | SIERRA CLUB | $13.0M | Jul 18, 2025 | 2025Q2 | ENVCAWSCI |
| SIERRA CLUB | SIERRA CLUB | $13.0M | Apr 17, 2025 | 2025Q1 | CAWENVBUD |
| BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. | BLUE CROSS AND BLUE SHIELD OF FLORIDA INC | $12.0M | Jul 21, 2025 | 2025Q2 | HCRMMMPHA |
| PIONEER PUBLIC AFFAIRS | BRIMSTONE ENERGY, INC. | $8.0M | Jul 18, 2025 | 2025Q2 | ENGENVTRA |
| CLEAN AIR TASK FORCE, INC. | CLEAN AIR TASK FORCE, INC. | $8.0M | Jul 18, 2025 | 2025Q2 | TAXCAWENG |
| PIONEER PUBLIC AFFAIRS | BRIMSTONE ENERGY, INC. | $8.0M | Apr 16, 2025 | 2025Q1 | ENGENVTRA |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $8.0M | Jan 21, 2025 | 2024Q4 | MMMPHACPT |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | NATIONAL MULTIPLE SCLEROSIS SOCIETY | $7.4M | Apr 22, 2024 | 2024Q1 | BUDHCRMMM |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | NATIONAL MULTIPLE SCLEROSIS SOCIETY | $6.1M | Oct 16, 2024 | 2024Q3 | BUDHCRMMM |
| CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $6.0M | Jan 18, 2025 | 2024Q4 | HCRMMMBUD |
| CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $6.0M | Oct 20, 2024 | 2024Q3 | HCRMMMBUD |
| CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $6.0M | Jul 20, 2024 | 2024Q2 | TRDHCRMMM |
| CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $6.0M | Apr 22, 2024 | 2024Q1 | HCRMMMBUD |
| NATIONAL READY MIXED CONCRETE ASSOCIATION | NATIONAL READY MIXED CONCRETE ASSOCIATION | $5.6M | Jul 30, 2025 | 2025Q2 | LBRTRATAX |
| NATIONAL READY MIXED CONCRETE ASSOCIATION | NATIONAL READY MIXED CONCRETE ASSOCIATION | $5.6M | Apr 17, 2025 | 2025Q1 | LBRTRATAX |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | NATIONAL MULTIPLE SCLEROSIS SOCIETY | $5.1M | Jan 21, 2025 | 2024Q4 | BUDHCRMMM |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $5.0M | Oct 18, 2024 | 2024Q3 | MMMPHACPT |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $5.0M | Jul 18, 2024 | 2024Q2 | CPTMMMPHA |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $5.0M | Apr 19, 2024 | 2024Q1 | MMMPHACPT |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | NATIONAL MULTIPLE SCLEROSIS SOCIETY | $4.2M | Jul 18, 2024 | 2024Q2 | BUDHCRMMM |
| TWENTY-FIRST CENTURY GROUP, INC. | CEMEX INC | $3.5M | Jul 18, 2025 | 2025Q2 | TRANATENV |
| TWENTY-FIRST CENTURY GROUP, INC. | CEMEX INC | $3.5M | Apr 21, 2025 | 2025Q1 | TRANATENV |
| BCBSM, INC. | BCBSM INC | $3.1M | Jan 19, 2025 | 2024Q4 | PHAHCRTAX |
| BCBSM, INC. | BCBSM INC | $3.1M | Oct 18, 2024 | 2024Q3 | BUDHCRTAX |
| BCBSM, INC. | BCBSM INC | $3.1M | Jul 19, 2024 | 2024Q2 | HCRTAXBUD |
| BCBSM, INC. | BCBSM INC | $3.0M | Jul 18, 2025 | 2025Q2 | HCRBUDPHA |
| WHITMER & WORRALL, LLC | CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | $3.0M | Feb 3, 2025 | 2024Q4 | MMMCPTPHA |
| WHITMER & WORRALL, LLC | CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | $3.0M | Oct 17, 2024 | 2024Q3 | MMMCPTPHA |
| BCBSM, INC. | BCBSM INC | $2.8M | Apr 18, 2025 | 2025Q1 | BUDHCRPHA |
| BCBSM, INC. | BCBSM INC | $2.8M | Apr 19, 2024 | 2024Q1 | HCRTAXBUD |
| BRADLEY ARANT BOULT CUMMINGS LLP | VULCAN MATERIALS COMPANY | $2.0M | Jul 21, 2025 | 2025Q2 | TRATRDBUD |
| ADVANCED POLICY CONSULTING, LLC | AMERICAN CEMENT ASSOCIATION (FORMERLY KNOWN AS PORTLAND CEMENT ASSOCIATION) | $2.0M | Jul 8, 2025 | 2025Q2 | ENVENGTRA |
| ADVANCED POLICY CONSULTING, LLC | AMERICAN CEMENT ASSOCIATION (FORMERLY KNOWN AS PORTLAND CEMENT ASSOCIATION) | $2.0M | Apr 16, 2025 | 2025Q1 | ENVENGTRA |
| WHITMER & WORRALL, LLC | CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | $2.0M | Jul 18, 2024 | 2024Q2 | MMMCPTPHA |
| WHITMER & WORRALL, LLC | CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | $2.0M | May 7, 2024 | 2024Q1 | MMMCPTPHA |
| BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. | BLUE CROSS AND BLUE SHIELD OF KANSAS INC | $1.0M | Jul 21, 2025 | 2025Q2 | HCRMMMPHA |
| GUIDEWELL MUTUAL HOLDING CORPORATION | GUIDEWELL MUTUAL HOLDING CORPORATION | $1.0M | Jul 21, 2025 | 2025Q2 | MMMPHA |
| BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. | BLUE CROSS AND BLUE SHIELD OF KANSAS INC | $1.0M | Apr 18, 2025 | 2025Q1 | HCRMMMPHA |
| GUIDEWELL MUTUAL HOLDING CORPORATION | GUIDEWELL MUTUAL HOLDING CORPORATION | $1.0M | Jan 17, 2025 | 2024Q4 | MMMPHA |
| BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. | BLUE CROSS AND BLUE SHIELD OF KANSAS INC | $500K | Jan 21, 2025 | 2024Q4 | HCRMMMPHA |
| AJW, INC. | GREAT PLAINS INSTITUTE - INDUSTRIAL INNOVATION INITIATIVE (I3) | Undisclosed | Jul 21, 2025 | 2025Q2 | MANTAXENG |
| GUIDEWELL MUTUAL HOLDING CORPORATION | GUIDEWELL MUTUAL HOLDING CORPORATION | Undisclosed | Apr 21, 2025 | 2025Q1 | MMMPHA |
| K |
| K |
| Buy |
| Apr 8, 2025 |
| $1,001 - $15,000 |
| 26d after |
| BLUE CROSS AND BLUE SHIELD OF KANSAS INC |
| 37% |
| Robert P. Bresnahan, Jr. | R | K | K | Buy | Apr 8, 2025 | $1,001 - $15,000 | 26d after | CLEAN AIR TASK FORCE, INC. | 37% |
| Robert P. Bresnahan, Jr. | R | K | K | Buy | Apr 8, 2025 | $1,001 - $15,000 | 26d after | GSK (FKA GLAXOSMITHKLINE INC.) | 37% |
| Robert P. Bresnahan, Jr. | R | K | K | Buy | Apr 8, 2025 | $1,001 - $15,000 | 26d after | KAISER FOUNDATION HEALTH PLAN INC | 37% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Apr 29, 2025 | $1,001 - $15,000 | 47d after | AMERICAN CEMENT ASSOCIATION (FORMERLY KNOWN AS PORTLAND CEMENT ASSOCIATION) | 36% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Apr 29, 2025 | $1,001 - $15,000 | 47d after | BLUE CROSS AND BLUE SHIELD OF KANSAS INC | 36% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Apr 29, 2025 | $1,001 - $15,000 | 47d after | CLEAN AIR TASK FORCE, INC. | 36% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Apr 29, 2025 | $1,001 - $15,000 | 47d after | GSK (FKA GLAXOSMITHKLINE INC.) | 36% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Apr 29, 2025 | $1,001 - $15,000 | 47d after | KAISER FOUNDATION HEALTH PLAN INC | 36% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Jan 24, 2025 | $1,001 - $15,000 | 48d before | AMERICAN CEMENT ASSOCIATION (FORMERLY KNOWN AS PORTLAND CEMENT ASSOCIATION) | 32% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Jan 24, 2025 | $1,001 - $15,000 | 48d before | BLUE CROSS AND BLUE SHIELD OF KANSAS INC | 32% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Jan 24, 2025 | $1,001 - $15,000 | 48d before | CLEAN AIR TASK FORCE, INC. | 32% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Jan 24, 2025 | $1,001 - $15,000 | 48d before | GSK (FKA GLAXOSMITHKLINE INC.) | 32% |
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Jan 24, 2025 | $1,001 - $15,000 | 48d before | KAISER FOUNDATION HEALTH PLAN INC | 32% |
| Val T. Hoyle | D | VMC | Vulcan Materials CO | Sell | Jun 6, 2025 | $1,001 - $15,000 | 85d after | VULCAN MATERIALS COMPANY | 36% |